HEALTH Gene Technologies, a dedicated Gene Fragment Analysis application provider, unveiled its Capillary Electrophoresis based diagnostic reagent kits in the National Clinical Laboratory Equipment and Application Academic Conference (NCLEAAC) and National Clinical Laboratory Equipment Expo, which lasted from April 26 to 28th 2016 in Ningbo, China.
Furthermore, HGT, together with Life Technologies (a member of Thermo Fisher), hosted a symposium on CE kits for clinical application. Hundreds of clinical professionals and specialists gathered in the symposium to discuss the advance of clinical diagnostics in Infectious Disease, Personalized Medicine and HPV molecular diagnostics.
HEALTH Gene Technologies, specialized in technology based on high-performance Capillary Electrophoresis and Advanced Fragment Analysis (AFA), is committed to developing and manufacturing simple, rapid and effective nucleic acid (DNA) testing solutions for molecular diagnostics, clinical research and forensic analysis.
About Health Gene Technologies
Health Gene Technologies founded in August 2011 is focused on gene analysis, molecular diagnostics product development, as well as the production and the sales of the products. HGT boasts 2,000 square meters of molecular diagnostics R&D laboratory and a 1,000 square metre GMP standard purification plant. It employs both domestic and foreign leading molecular diagnostics and production management personnel, led by the professional R&D team.
Inspired by our motto “Health Technologies • Healthy Life” HGT commits to high standard AFA product development. The unique AFA technology is dedicated to independent R&D and production of nucleic acid molecule detection products. The products comply with leading international standards for human ID and paternity identification, infectious pathogen detection, individualized medication guide and provides the most superior molecular detection solutions.
For more information, please visit: